Effects of D-003, a mixture of high molecular weight aliphatic acids from sugar cane wax, on bones from ovariectomized rats

Drugs under Experimental and Clinical Research

Volumn 30, Issue 1, 2004, Pages 35-41

  Noa, M ^a   Mas R ^a   Mendoza, S ^a   Gamez R ^a   Mendoza, N ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CHOLESTEROL; D 003; FATTY ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEVALONIC ACID; POLYSORBATE; UNCLASSIFIED DRUG; WAX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; ENZYME REGULATION; FEMALE; MOLECULAR WEIGHT; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; RAT; SUGARCANE; TRABECULAR BONE;

ADMINISTRATION, ORAL; ALENDRONATE; ANIMALS; BONE DENSITY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS; FEMALE; FEMUR; LUMBAR VERTEBRAE; OSTEOPOROSIS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 2342439784     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Watts N. Osteoporosis: Prevention, detection and treatment. J. Med. Association of Georgia, September 1997, pp. 224-226.
2. Looker A.C., Johnston C.C., Wahner H.W., et al. Prevalence of low femoral bone density in older US women from NHANES III. J. Bone Miner. Res., 10, 796, 1995.
3. Bagi C., Ammann P., Rizzoli R., Miller S. Effect of estrogen deficiency on cancellous and cortical bone structure and strength of the femoral neck in rats. Calcif. Tissue Int., 61, 336, 1997.
4. Thompson D., Simmons H., Pirie C., Ke H. FDA Guidelines and animal models for osteoporosis. Bone, 17, 125, 1995.
5. Russell R.G., Rogers M.J., Frith J.C., et al. The pharmacology of bisphosphonates and new insights into their mechanisms of action. J. Bone Miner. Res., 14 (Suppl 2), 53, 1999.
6. Fisher J.E., Rogers M.J., Halasy J.M., et al. Alendronate mechanism of action: Geranylgeraniol, an intermediate of the mevalonate pathway, prevents inhibition of osteoclasts formation, bone resorption and kinase activation in vitro. Proc. Natl. Acad. Sci. USA, 96, 133, 1999.
7. Mundy G., Garret R., Harris S., et al. Stimulation of bone formation in vitro and in rodents by statins. Science, 286, 1946, 1999.
8. Meier C., Schlienger R., Kraenzlin M. HMG-CoA reductase inhibitors and the risk of fractures. JAMA, 283, 3205, 2000.
9. Parhami F., Morrow A., Balucan J., Tintut Y. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol., 17, 680, 1997.
10. Xu H., Watkins B., Seifert M. Vitamin E stimulates trabecular bone formation and alters epiphyseal cartilage morphometry Calc. Tissue Int., 57, 293, 1995.
11. González L., Marrero D., Laguna A., et al, inventors. Laboratorios Dalmer SA, assignee. Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses. Republic of South Africa patent 98-2744, December 30, 1998.
12. Menéndez R., Mas R., Amor A.M., et al. Inhibition of cholesterol biosynthesis in cultured fibroblasts by D-003, a mixture of very long chain saturated fatty acids. Pharmacol. Res., 44, 299, 2001.
13. Gámez R., Mendoza S., Mas R., et al. Dose-dependent cholesterol-lowering effects of D-003 on normocholesterolemic rabbits. Curr. Ther. Res. Clin. Exp., 61, 8, 2000.
14. Castaño G., Mas R., Fernández L., et al. Assessment of the effects of D-003, a new antiplatelet and lipid-lowering compound, in healthy volunteers. Drugs R&D, 3, 337, 2002.
15. Castaño G., Menéndez R., Mas R., et al. Effects of D-003 on lipid profile and lipid peroxidation in healthy volunteers. Clin. Drug Invest., 23, 193, 2003.
16. Menéndez R., Mas R., Pérez Y., et al. Inhibition of rat lipoprotein lipid peroxidation by the oral administration of D-003, a mixture of very long chain saturated fatty acids. Can. J. Physiol. Pharmacol., 80, 13, 2002.
17. 3H-ethidroante in rat and mouse bones. Bone, 19, 281, 1996.
18. Mosekilde L., Danielsen C., Knudsen B. The effect of aging and ovariectomy on the vertebral bone mass and biochemical properties of mature rats. Bone, 14, 1, 1993.
19. Parfitt A., Drezner M., Glorieux F., et al. Bone histomorphometry. Standardization of nomenclature, symbols, and units. J. Bone Miner. Res., 2, 595, 1987.
20. Coro R.M., Borrajero I. DIGIPAT Un sistema cubano para morfometria de imágenes. Rev. Latinoam. Patol., 39, 9, 1996.
21. Jensen J.E., Kollerup G., Sorensen H.A., Sorenson O.H. Intraindividual variability on bone markers in the urine. Scand. J. Clin. Lab. Invest., 57, 29, 1997.